Shitanshu Uppal

Fulvestrant + Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer (NCT03643510)

GROINSS-V I: Sentinel Node Dissection as Sole Groin Staging in Early-Stage Vulvar Cancer

EMPOWER-Cervical 1 (GOG-3016 / ENGOT-cx9): Cemiplimab vs. Chemotherapy in Recurrent/Metastatic Cervical Cancer

PORTEC-4a: Molecular Profile-Based Adjuvant Treatment for High-Intermediate Risk Endometrial Cancer

AtTEnd: Atezolizumab plus Chemotherapy for Advanced or Recurrent Endometrial Cancer

SOLO2/ENGOT-Ov21: Maintenance Olaparib in Platinum-Sensitive Relapsed Ovarian Cancer (Final OS Analysis)

AURELIA: Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer

RTOG 90-01 (Morris): Pelvic Radiation + Concurrent Cisplatin/5-FU vs Extended-Field Radiation Alone for Locally Advanced Cervical Cancer

GOG 242: Second Curettage for Low-Risk Nonmetastatic GTN

GOG 174: Weekly Methotrexate vs. Pulsed Dactinomycin for Low-Risk GTN